Germinal Center Formation, Immunoglobulin Class Switching, and Autoantibody Production Driven by "non Alpha/beta" T Cells
Overview
General Medicine
Affiliations
The production of class-switched antibodies, particularly immunoglobulin (Ig) G1 and IgE, occurs efficiently in T cell receptor (TCR) alpha-/- mice that are congenitally devoid of alpha/beta T cells. This finding runs counter to a wealth of data indicating that IgG1 and IgE synthesis are largely dependent on the collaboration between B and alpha/beta T cells. Furthermore, many of the antibodies synthesized in TCR alpha-/- mice are reactive to a similar spectrum of self-antigens as that targeted by autoantibodies characterizing human systemic lupus erythematosus (SLE). SLE, too, is most commonly regarded as an alpha/beta T cell-mediated condition. To distinguish whether the development of autoantibodies in TCR alpha-/- mice is due to an intrinsic de-regulation of B cells, or to a heretofore poorly characterized collaboration between B and "non-alpha/beta T" cells, the phenotype has been reconstituted by transfer of various populations of B and non-alpha/beta T cells including cloned gamma/delta T cells derived from TCR alpha-/- mice, to severe combined immunodeficient (SCID) mice. The results establish that the reproducible production of IgG1 (including autoantibodies) is a product of non-alpha/beta T cell help that can be provided by gamma/delta T cells. This type of B-T collaboration sustains the production of germinal centers, lymphoid follicles that ordinarily are anatomical signatures of alpha/beta T-B cell collaboration. Thus, non-alpha/beta T cell help may drive Ig synthesis and autoreactivity under various circumstances, especially in cases of alpha/beta T cell immunodeficiency.
Charmetant X, Rigault G, Chen C, Kaminski H, Visentin J, Taton B Transpl Int. 2025; 38:12859.
PMID: 39944220 PMC: 11815947. DOI: 10.3389/ti.2025.12859.
Ran R, Trapecar M, Brubaker D bioRxiv. 2024; .
PMID: 39071278 PMC: 11275756. DOI: 10.1101/2024.07.18.604156.
γδ T cells: origin and fate, subsets, diseases and immunotherapy.
Hu Y, Hu Q, Li Y, Lu L, Xiang Z, Yin Z Signal Transduct Target Ther. 2023; 8(1):434.
PMID: 37989744 PMC: 10663641. DOI: 10.1038/s41392-023-01653-8.
The emerging roles of γδ T cells in cancer immunotherapy.
Mensurado S, Blanco-Dominguez R, Silva-Santos B Nat Rev Clin Oncol. 2023; 20(3):178-191.
PMID: 36624304 DOI: 10.1038/s41571-022-00722-1.
Biradar S, Lotze M, Mailliard R Viruses. 2020; 12(12).
PMID: 33348583 PMC: 7766279. DOI: 10.3390/v12121455.